High-Risk Ulcerative Colitis

In this Healio Gastroenterology video exclusive, Miguel Regueiro, MD, FACG, discussed how anti-TNF therapy should be used as first-line therapy for treatment of inflammatory bowel disease.

Eli Lilly and Co. announced positive top-line phase 3 results of mirikizumab for moderate to severe ulcerative colitis.

LAS VEGAS — Inflammatory bowel disease clinical trials underrepresent racial and ethnic minority groups, according to a presentation at the ACG Annual Scientific Meeting.

In this video exclusive, Tina Aswani Omprakash, a patient advocate with Crohn's disease, discussed how telemedicine changed patient care.

Researchers found that specific foods and nutrients correlated with species known to have mucosal protection and anti-inflammatory effects, according to data published in Gut.

Regardless of prior tumor necrosis factor inhibitor failure status, Xeljanz was efficacious in patients with ulcerative colitis, according to a study published in Clinical Gastroenterology and Hepatology.

A machine learning image model describing Crohn’s disease phenotypes may impact individualized care for children with Crohn’s, according to a presenter at the Crohn’s and Colitis Congress.